Marriott lost its bid to delay an antitrust trial set to start October 25 over its alleged role in an industrywide scheme to rig online advertising auctions, when a federal judge in Texas ruled Wednesday, October 20, that its concerns about a magistrate’s decision were “unfounded.”
Judge Robert W. Schroeder III denied the hotel chain’s emergency motion to postpone a trial while he reviews a federal magistrate’s report advising him to consider antitrust claims by TravelPass, which brokers hotel room sales through digital advertisements—under a per se legal framework.
Related: Marriott Looks To Delay Antitrust Trial With Emergency Motion
The lawsuit, which has been filed by class-action law firm Hagens Berman, contests that Choice Hotels International, Hilton, Hyatt Hotels Corporation, InterContinental Hotels Group, Marriott International and Wyndham Worldwide took part in an anticompetitive agreement to reduce or eliminate online branded keyword search advertising against each other. Hagens Berman maintains that as a result of this, consumers were deprived of the “free flow of competitive information,” raising the price of hotel rooms as well as the cost of finding rooms.
The lawsuit states that each hotel defendant entered into an agreement to refrain from using specific online advertising methods to compete for consumers. The agreement prevented competing hotel entities from bidding for online advertising that used their competitors’ brand names. In the example included in a release from Hagens Berman, Hilton Hotels declined to bid on keywords that would prompt its hotels to appear in searches for Hyatt-branded properties, in turn making it more difficult for consumers to obtain information about competing hotels. Because of this, Hagens Berman maintains that the defendants made it more difficult to compare and contrast information such as price and quality when booking hotel stays.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million
Apr 29, 2024 by
CPI
South Korean Regulator Approves LG Uplus and Kakao Mobility EV Charging Venture
Apr 29, 2024 by
CPI
Federal Judge Dismisses Doctors’ Antitrust Suit Against Ohio Health System
Apr 29, 2024 by
CPI
Paramount CEO Bob Bakish Steps Down as Merger Inches Closer
Apr 29, 2024 by
CPI
EU Brands Apple’s iPadOS as Gatekeeper in Tech Crackdown
Apr 29, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI